MedTrace Logo

Daily Tenofovir DF to Prevent HIV Infection Among Sex Workers in Cambodia

NCT00078182 · Status: WITHDRAWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL

Last updated 2016-12-14

No results posted yet for this study

Summary

Tenofovir disoproxil fumarate (also known as tenofovir DF or Viread) is used with other anti-HIV drugs to treat HIV infection. Taking tenofovir DF every day may also prevent HIV infection. This study will determine if taking a tenofovir DF tablet every day is safe and effective in preventing HIV infection. Participants in the study will be sex workers in Phnom Penh, Cambodia.

Conditions

  • HIV Infections
  • HIV Seronegativity

Interventions

DRUG

Tenofovir DF

Sponsors & Collaborators

  • NCHADS - Ministry of Health of Cambodia

    collaborator OTHER

  • Kirby Institute

    collaborator OTHER_GOV

  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Principal Investigators

  • Kimberly Shafer, MD

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Countries

  • Cambodia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00078182 on ClinicalTrials.gov